Current Patent Journal
Publication of patent applications and events is undertaken by the Intellectual Property Office once a week. New notices are posted on the site every Monday and will remain published for 20 working days. Notices are also archived as appropriate every Monday.
Date of Journal: 04/11/2019
| Date Published | Date of Application in Bailiwick | Patent Title | Field of Invention | Registered Proprietor | Overseas Registration, Jurisdiction, Number & Link to Web | Bailiwick Registered Agent | Supporting Documents |
|---|---|---|---|---|---|---|---|
| 14/10/19 | 07/10/19 | Benzimidazole derivatives | A61K 31/4433; A61K 31/4439; A61P 35/00; C07D 401/04; C07D 401/12; C07D 401/14; C07D 403/04; C07D 403/14; C07D 405/14; C07D 409/14; C07D 413/14; C07D 471/04 | Pfizer Inc. | European Patent Office | David Evans (Collas Crill) | - |
| 14/10/19 | 07/10/19 | Novel selective androgen receptor modulators | C07D 217/26; A61K 31/4725; A61P 3/00; A61P 5/26; A61P 5/28; A61P 19/00; A61P 21/00; A61P 25/00; C07C 255/58; C07D 205/04; C07D 207/08; C07D 211/22; C07D 285/10; C07D 401/04; C07D 417/04 | Pfizer Inc. | European Patent Office | David Evans (Collas Crill) | - |
| 28/10/19 | 22/10/19 | Substituted tricyclic compounds as FGFR inhibitors | C07D 471/14; C07D 471/22; C07D 491/22; C07D 495/14; C07D 498/14; A61K 31/519; A61K 31/4375; A61P 35/00 | Incyte Holdings Corporation | European Patent Office | David Evans (Collas Crill) | - |
